Prognostic factors in stage IB non-small cell lung cancer according to the 8th edition of the TNM staging system after curative resection | Zendy

Youngkyu Moon | Zendy; Si Young Choi | Zendy; Jae Kil Park | Zendy; Kyo Young Lee | Zendy

Open Access

Prognostic factors in stage IB non-small cell lung cancer according to the 8th edition of the TNM staging system after curative resection

Author(s) -

Youngkyu Moon,

Si Young Choi,

Jae Kil Park,

Kyo Young Lee

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.11.71

Subject(s) - medicine , lymphovascular invasion , stage (stratigraphy) , oncology , hazard ratio , chemotherapy , lung cancer , adjuvant therapy , tnm staging system , cancer , metastasis , neoplasm staging , paleontology , confidence interval , biology

Patients with stage IB non-small cell lung cancer (NSCLC) with poor prognostic factors can be treated selectively with postoperative adjuvant chemotherapy. The aim of this study was to identify the prognostic factors of stage IB NSCLC according to the new 8 th edition of the tumor, node, and metastasis (TNM) staging system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research